パシテア・セラピューティクス
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.16 | $0 | -$9.5B |
| 2026 Q1 | -0.41 | $0 | -$5M |
| 2025 Q4 | -0.89 | $0 | -$5M |
| 2025 Q3 | -0.41 | $0 | -$3M |
| 2025 Q2 | -0.66 | $0 | -$4M |
| 2025 Q1 | -3.25 | $0 | -$3M |
| 2024 Q4 |
| -2.90 |
| $0 |
| -$2M |
| 2024 Q3 | -2.87 | $0 | -$3M |